FOLLOW US

Day One to acquire Mersana Therapeutics

America November 14, 2025

Day One to Acquire Mersana Therapeutics in High-Stakes $285M Cancer Drug Deal

In a dramatic move that reshapes the biopharma landscape, Day One Biopharmaceuticals revealed Thursday that it will acquire Mersana Therapeutics…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter